Valacyclovir Hydrochloride

CHEMBL1201110 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
360.8 g/mol
LogP
Phase
4

A hydrochloride salt form of valacyclovir with the same therapeutic properties. This antiviral medication is a prodrug that is converted in the body into acyclovir, used to treat infections caused by herpes viruses including genital herpes, cold sores, shingles (herpes zoster), and chickenpox.

आणविक भार

360.8000 g/mol

TPSA

147.00 Ų

चिकित्सीय क्षेत्र

क्रिया का तंत्र

Administered as an inactive precursor that is metabolically converted to its active form in the body. This prodrug design improves bioavailability, absorption, or targeted delivery compared to the active compound.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

तंत्र

Administered as an inactive precursor that is metabolically converted to its active form in the body. This prodrug design improves bioavailability, absorption, or targeted delivery compared to the active compound.

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21.Cl

InChI

InChI=1S/C13H20N6O4.ClH/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20;/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20);1H/t8-;/m0./s1

Molecular Formula

C13H21ClN6O4

HBD / HBA

4 / 7

घूर्णनीय बंधन

8

भारी परमाणु

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

A hydrochloride salt form of valacyclovir with the same therapeutic properties. This antiviral medication is a prodrug that is converted in the body into acyclovir, used to treat infections caused by herpes viruses including genital herpes, cold sores, shingles (herpes zoster), and chickenpox.

Administered as an inactive precursor that is metabolically converted to its active form in the body. This prodrug design improves bioavailability, absorption, or targeted delivery compared to the active compound.

Yes, Valacyclovir Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201110. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 135398741. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.